TRiP research group


Dr. Bettina Lange, MD

Research interests/ Focus of work:
Schizophrenia, Endocannabinoid system, Clinical Trials

Academic education:
2005 – 2011 Study of Medicine, Eberhardt-Karls-University Tuebingen
2011 Medical license
Doctoral thesis:
2014 „Modification of the gut microbiome by vegetarian diet", Eberhardt-Karls-University Tuebingen
Professional experience:
2012 - 2014 Resident, Dept. of Neurology, University Hospital Giessen and Marburg, Marburg
since 2014 Resident, Dept. of Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim
2017 B. Lange, J. K. Mueller, F. M. Leweke, J. M. Bumb (2017) How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review. Expert Opin Pharmacother 18:351-362
2016 F. M. Leweke, J. K. Mueller, B. Lange, C. Rohleder: Therapeutic potential of cannabinoids in psychosis. Biol Psychiatry 79:604-612